This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Alexandria (ARE) Beats Q1 AFFO Estimates, Narrows '24 Guidance
by Zacks Equity Research
Alexandria's (ARE) Q1 results reflect healthy leasing activity and rental rate growth.
What's in the Cards for Healthpeak (DOC) This Earnings Season?
by Zacks Equity Research
While Healthpeak's (DOC) Q1 earnings are likely to have benefited from the healthy demand for lab real estate assets, high interest expenses raise concern.
Should Investors Retain Healthpeak (DOC) Stock for Now?
by Zacks Equity Research
Solid demand for lab assets and rising healthcare expenditure by senior citizens bode well for Healthpeak (DOC). However, competition from peers and high interest rates are woes.
Here's What Key Metrics Tell Us About Physicians Realty Trust (DOC) Q4 Earnings
by Zacks Equity Research
Although the revenue and EPS for Physicians Realty Trust (DOC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Physicians Realty Trust (DOC) Meets Q4 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 1.82%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Compared to Estimates, Physicians Realty Trust (DOC) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Physicians Realty Trust (DOC) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Physicians Realty Trust (DOC) Matches Q3 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 1.17%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Compared to Estimates, Physicians Realty Trust (DOC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Physicians Realty Trust (DOC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Physicians Realty Trust (DOC) Meets Q2 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 0.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Alexandria Real Estate Equities (ARE) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Alexandria Real Estate Equities (ARE) delivered FFO and revenue surprises of 1.82% and 2.10%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Misses Q1 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of -4% and 0.05%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Extra Space Storage (EXR) Misses Q1 FFO and Revenue Estimates
by Zacks Equity Research
Extra Space Storage (EXR) delivered FFO and revenue surprises of -1.46% and 2.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Kilroy Realty (KRC) Soars 6.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Kilroy Realty (KRC) was a big mover last session on higher-than-average trading volume.
Physicians Realty Trust (DOC) Q4 FFO Match Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 0.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Misses Q3 FFO and Revenue Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of -3.70% and 0.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Piedmont Office (PDM) Q3 FFO Match Estimates
by Zacks Equity Research
Piedmont Office (PDM) delivered FFO and revenue surprises of 0% and 4.47%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Community Healthcare Trust (CHCT) Tops Q3 FFO and Revenue Estimates
by Zacks Equity Research
Community Healthcare Trust (CHCT) delivered FFO and revenue surprises of 6.78% and 1.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
VICI Properties Inc. (VICI) Q3 FFO Meet Estimates
by Zacks Equity Research
VICI Properties Inc. (VICI) delivered FFO and revenue surprises of 0% and 1.54%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Matches Q2 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 0.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Surpasses Q2 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 5.41% and 2.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Pebblebrook Hotel (PEB) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Pebblebrook Hotel (PEB) delivered FFO and revenue surprises of 5.88% and 5.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Physicians Realty (DOC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Physicians Realty (DOC) stock based on the movements in the options market lately.
Physicians Realty Trust (DOC) Lags Q1 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of -3.57% and 2.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Public Storage (PSA) Tops Q1 FFO and Revenue Estimates
by Zacks Equity Research
Public Storage (PSA) delivered FFO and revenue surprises of 1.67% and 0.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Q4 FFO Match Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 2.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?